CompaniesMeridian Medical Technologies

Meridian Medical Technologies

defunct

About

Defunct Company

Areas of Focus

Categories

MergedTerminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

30

By Phase

PHASE2: 1

By Status

RECRUITING: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2024

2025

2026

2027

Today

Hover over trial bars to see details

Recent Trials

NCT06810726Lead Sponsor

Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.

PHASE2Recruiting

30 participants

Started: Apr 15, 2025 · Completed: Aug 15, 2026

Funding History (20)

DEFM14A

Dec 16, 2002

DFAN14A

Dec 10, 2002

DEFA14A

Dec 10, 2002

DFAN14A

Oct 23, 2002

DFAN14A

Oct 22, 2002

8-K

Oct 22, 2002

DFAN14A

Oct 21, 2002

DEFA14A

Oct 21, 2002

8-K

Dec 13, 2001

DEF 14A

Nov 2, 2001

Related Companies

Altaris

acquired